Navigation Links
Singapore research team first place in Brain-Computer Interface contest
Date:12/18/2008

The Brain-Computer Interface (BCI) research team at Singapore's Infocomm Research (I2R) has won first place in the worldwide BCI Competition IV, 2008, in all three electroencephalogram (EEG) based non-invasive BCI categories.

The results were announced on Dec. 12 at the international Neural Information Processing Systems (NIPS) conference in Vancouver, Canada.

The Singapore scientists designed the non-invasive BCI technology to provide a direct communication channel between the human brain and the computer, so that physically handicapped individuals, such as "locked-in" patients who have lost effective communication and interactive abilities, would be able to communicate and interact with their environment through thoughts, rather than relying on normal, neuromuscular pathways.

The scientists at I2R, which is one of the research institutes under Singapore's A*STAR (Agency for Science, Technology and Research) and which is headquartered at the Asian city-state's new R&D epicenter, Fusionopolis, have developed new algorithms and novel techniques that have dramatically improved the efficiency, accuracy and convenience of non-invasive BCI systems.

In Singapore, research work and clinical tests are currently being carried out on a variety of BCI applications such as a communication platform for paralyzed patients, rehabilitation for stroke patients and the treatment for children with Attention-Deficit Hyperactivity Disorder.

For more information about Singapore's BCI technology: http://www.i2r.a-star.edu.sg/enews/technology/bci.htm

During the competition, the Singapore scientists demonstrated clear strengths in EEG-based non-invasive BCI technology among a total of 35 submissions by scientists from the United States, Europe, Australia, and Asia.

The BCI Competition IV, funded by the European Network of Excellence PASCAL2, was organi
'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1 2

Related biology news :

1. Singapore opens Fusionopolis, its second major R&D hub in 5 years
2. Singapores BIOPOLIS and FUSIONOPOLIS on stage in Boston this week
3. Ludwig Institute for Cancer Research to set up its first Asian branch in Singapore
4. Rare cancer-causing syndrome found, for the first time, in Singapore
5. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
6. Singapore National Science and Technology Awards
7. Researchers advance knowledge of little nano-machines in our body
8. New manual presents robust, state-of-the-art proteomics methods for teaching and research
9. Harmonizing Biobank Research Conference in 2009
10. F-MARC funds more soccer and health research
11. No quick or easy technological fix for climate change, researchers say

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...in harmony with their arboreal hosts. But new rese...heir trees of choice, the ants can get destructive... in the November issue of the American Naturalist...ve trees, and it reopens a centuries-old debate on...s and certain species of plants and trees have coz...
(Date:11/5/2009)...rded a training grant in the amount of $2,756,719 ...rative Graduation Education and Research Training ...be awarded to Kent State. The grant, which is fund...t of 2009, runs through 2014. , The grant funds ...ic resource sensing (EARS). The purpose of the pro...
(Date:11/4/2009)... turns out, hold the power to help militaries and ...ean up toxic waste on test sites. , Compounds kn... back in World War II and have been used in milita...unds are often used to propel tank shells and act ...h increased knowledge of their environmentally har...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2MedCath Names Art Parker Executive Vice President and Chief Financial Officer 58084 1MedCath Names Art Parker Executive Vice President and Chief Financial Officer 58084 2Anthem Blue Cross and Blue Shield Awarded NCQAs Accreditation Status of Excellent 58081 1Anthem Blue Cross and Blue Shield Awarded NCQAs Accreditation Status of Excellent 58081 2One Health Commission Teaming Up With World Rabies Day to Spread the One Health Message 58078 1One Health Commission Teaming Up With World Rabies Day to Spread the One Health Message 58078 2
...s discovered a new ultra-small species of bacteria...hin the ice of a Greenland glacier at a depth of n...ersist in this low-temperature, high-pressure, red...rticularly useful for studying how life, in genera...s on Earth and possibly elsewhere in the solar sys...
...m among scientists has long been that birds acquir...ood health from their environment, but a new Unive...ually born with those bacteria. , Lead author Adr... at the American Society for Microbiology General ...ns for the poultry industry and for food safety. ,...
... commonplace everyday events than meets the eye. T...m a tap, are two such events, both of which involv...cated mathematical techniques to describe, analyse...in common between many such singular events across...actions to the very formation of the universe itse...
Other Biology News:A survivor in Greenland: A novel bacterial species is found trapped in 120,000-year-old ice 2Study finds healthy intestinal bacteria within chicken eggs 2Finding out what the Big Bang and ink jets have in common 2Finding out what the Big Bang and ink jets have in common 3
(Date:11/5/2009)... Call on Thursday, November 5, 2009 at 4:30 p.m. E...5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceutica...OGXI ) today reported unaudited financial results ...ber 30, 2009 and reviewed the Company,s highlights...g consolidated results reflect the operations of O...
(Date:11/5/2009)...N.Y., Nov. 5 BioSpecific...ceutical company developing first-in-class collage... results for the third quarter ended September 30,...ptember of this year, the FDA,s Arthritis Advisory...2-0, the approval of XIAFLEX(TM) for the treatment...
(Date:11/5/2009)..., Texas, Nov. 5 Wound Ma...ay that it has entered into a Letter of Intent to ...Health Technologies, Inc. (OTC Bulletin Board: VHG...00 in cash and debt, 4,000,000 shares of WNDM and ... on the Veriscrip technology being acquired from V...
(Date:11/5/2009)...alif., Nov. 5 WaferGen B...ing developer of state-of-the-art genetic analysis...Ph.D. has joined the company,s Scientific Advisory...and commercializing novel molecular diagnostics fo...the development of computational biology systems f...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
...timicrobial sets the new global standard to er...and lethal,microorganisms commonly found in health... C. difficile, NEWARK, N.J., Aug. ... Ygiene(TM) Hospital Grade antimicrobial against,a... of microorganisms which,represent the major sourc...
...First Diagnostic Test Based on Company,s, microR...dical Center, Approved for C...dite Commercialization of its ... Three Additional microRNA-based Cancer Tests in ... Israel and JERSEY CITY, New Jersey, August 19, Ro...
...NUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS )...ts full year 2008 guidance. The Company has record...nses and certain balance sheet accounts,to record ...ation that were,not appropriately recorded in prio...cial Accounting Standard ("SFAS") No. 123R on Janu...
Other Biology Technology:BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World 2BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World 3BioNeutral's Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World 4Rosetta Genomics Reports Second Quarter 2008 Financial Results 2Rosetta Genomics Reports Second Quarter 2008 Financial Results 3Rosetta Genomics Reports Second Quarter 2008 Financial Results 4Rosetta Genomics Reports Second Quarter 2008 Financial Results 5Rosetta Genomics Reports Second Quarter 2008 Financial Results 6Rosetta Genomics Reports Second Quarter 2008 Financial Results 7Rosetta Genomics Reports Second Quarter 2008 Financial Results 8Rosetta Genomics Reports Second Quarter 2008 Financial Results 9Rosetta Genomics Reports Second Quarter 2008 Financial Results 10Rosetta Genomics Reports Second Quarter 2008 Financial Results 11Rosetta Genomics Reports Second Quarter 2008 Financial Results 12VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 2VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 3VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 4
Hamster serum from Equitech-Bio
... in several versions. The Captiva 0.2 um and 0.45 ...itated protein samples for LC/MS analysis. Filtrat... clogging of expensive HPLC columns. The Captiva 1...ates are designed for clarifying highly particle-l...
...ith CyScribe GFX Purification Kit, 25 reactions. F...-labeled cDNA.Optimized reagents are packaged toge...lexible and optimized protocols can be used for pe...5-labeled nucleotides.Reliable purification using ...
...m - dUTP with CyScribe GFX Purification Kit, 50 re...3- and Cy5-labeled cDNA.Optimized reagents are pac...fication.Flexible and optimized protocols can be u...Cy3- or Cy5-labeled nucleotides.Reliable purificat...
Biology Products: